BiotechTube
Home/BioArdis/Farzad Haerizadeh, Ph.D.
FH

Farzad Haerizadeh, Ph.D.

Chief Scientific Officer, Large molecule and Cell Therapy

BioArdis

Therapeutic Areas

OncologyImmuno-oncologyDermatology

BioArdis Pipeline

DrugIndicationPhase
FGFR4 InhibitorHepatocellular Carcinoma (HCC) & other cancersPre-clinical
CD73 InhibitorOncology (Tumor Microenvironment Modulation)Pre-clinical
Undisclosed Oncology ProgramOncologyPre-clinical
Dermatological TherapyUndisclosed Dermatological ConditionLead Optimization
CAR-T TherapiesSolid TumorsIND-enabling

Leadership Team at BioArdis

HJ
Helena Jiang
Vice President of Operations
FK
Frank Kayser, Ph.D.
Chief Scientific Officer, Small Molecule
View full BioArdis profile